[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Edaravone Market Research Report 2024(Status and Outlook)

July 2024 | 108 pages | ID: G1032323B483EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

The Global Edaravone Market Size was estimated at USD 1030.37 million in 2023 and is projected to reach USD 1349.53 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.

This report provides a deep insight into the global Edaravone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Edaravone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Edaravone market in any manner.

Global Edaravone Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Mitsubishi Tanabe Pharma

Simcere

Taj Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Unichem Laboratories Ltd

UCB India Ltd

Piramal Healthcare

Market Segmentation (by Type)

Oral Edaravone

Injection Edaravone

Market Segmentation (by Application)

Hospital

Clinic

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Edaravone Market
  • Overview of the regional outlook of the Edaravone Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Edaravone Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Edaravone
1.2 Key Market Segments
  1.2.1 Edaravone Segment by Type
  1.2.2 Edaravone Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 EDARAVONE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Edaravone Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Edaravone Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 EDARAVONE MARKET COMPETITIVE LANDSCAPE

3.1 Global Edaravone Sales by Manufacturers (2019-2024)
3.2 Global Edaravone Revenue Market Share by Manufacturers (2019-2024)
3.3 Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Edaravone Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Edaravone Sales Sites, Area Served, Product Type
3.6 Edaravone Market Competitive Situation and Trends
  3.6.1 Edaravone Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Edaravone Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 EDARAVONE INDUSTRY CHAIN ANALYSIS

4.1 Edaravone Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF EDARAVONE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 EDARAVONE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Edaravone Sales Market Share by Type (2019-2024)
6.3 Global Edaravone Market Size Market Share by Type (2019-2024)
6.4 Global Edaravone Price by Type (2019-2024)

7 EDARAVONE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Edaravone Market Sales by Application (2019-2024)
7.3 Global Edaravone Market Size (M USD) by Application (2019-2024)
7.4 Global Edaravone Sales Growth Rate by Application (2019-2024)

8 EDARAVONE MARKET SEGMENTATION BY REGION

8.1 Global Edaravone Sales by Region
  8.1.1 Global Edaravone Sales by Region
  8.1.2 Global Edaravone Sales Market Share by Region
8.2 North America
  8.2.1 North America Edaravone Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Edaravone Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Edaravone Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Edaravone Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Edaravone Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Mitsubishi Tanabe Pharma
  9.1.1 Mitsubishi Tanabe Pharma Edaravone Basic Information
  9.1.2 Mitsubishi Tanabe Pharma Edaravone Product Overview
  9.1.3 Mitsubishi Tanabe Pharma Edaravone Product Market Performance
  9.1.4 Mitsubishi Tanabe Pharma Business Overview
  9.1.5 Mitsubishi Tanabe Pharma Edaravone SWOT Analysis
  9.1.6 Mitsubishi Tanabe Pharma Recent Developments
9.2 Simcere
  9.2.1 Simcere Edaravone Basic Information
  9.2.2 Simcere Edaravone Product Overview
  9.2.3 Simcere Edaravone Product Market Performance
  9.2.4 Simcere Business Overview
  9.2.5 Simcere Edaravone SWOT Analysis
  9.2.6 Simcere Recent Developments
9.3 Taj Pharmaceuticals Ltd.
  9.3.1 Taj Pharmaceuticals Ltd. Edaravone Basic Information
  9.3.2 Taj Pharmaceuticals Ltd. Edaravone Product Overview
  9.3.3 Taj Pharmaceuticals Ltd. Edaravone Product Market Performance
  9.3.4 Taj Pharmaceuticals Ltd. Edaravone SWOT Analysis
  9.3.5 Taj Pharmaceuticals Ltd. Business Overview
  9.3.6 Taj Pharmaceuticals Ltd. Recent Developments
9.4 Sun Pharmaceutical Industries Ltd.
  9.4.1 Sun Pharmaceutical Industries Ltd. Edaravone Basic Information
  9.4.2 Sun Pharmaceutical Industries Ltd. Edaravone Product Overview
  9.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Product Market Performance
  9.4.4 Sun Pharmaceutical Industries Ltd. Business Overview
  9.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
9.5 Unichem Laboratories Ltd
  9.5.1 Unichem Laboratories Ltd Edaravone Basic Information
  9.5.2 Unichem Laboratories Ltd Edaravone Product Overview
  9.5.3 Unichem Laboratories Ltd Edaravone Product Market Performance
  9.5.4 Unichem Laboratories Ltd Business Overview
  9.5.5 Unichem Laboratories Ltd Recent Developments
9.6 UCB India Ltd
  9.6.1 UCB India Ltd Edaravone Basic Information
  9.6.2 UCB India Ltd Edaravone Product Overview
  9.6.3 UCB India Ltd Edaravone Product Market Performance
  9.6.4 UCB India Ltd Business Overview
  9.6.5 UCB India Ltd Recent Developments
9.7 Piramal Healthcare
  9.7.1 Piramal Healthcare Edaravone Basic Information
  9.7.2 Piramal Healthcare Edaravone Product Overview
  9.7.3 Piramal Healthcare Edaravone Product Market Performance
  9.7.4 Piramal Healthcare Business Overview
  9.7.5 Piramal Healthcare Recent Developments

10 EDARAVONE MARKET FORECAST BY REGION

10.1 Global Edaravone Market Size Forecast
10.2 Global Edaravone Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Edaravone Market Size Forecast by Country
  10.2.3 Asia Pacific Edaravone Market Size Forecast by Region
  10.2.4 South America Edaravone Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Edaravone by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Edaravone Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Edaravone by Type (2025-2030)
  11.1.2 Global Edaravone Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Edaravone by Type (2025-2030)
11.2 Global Edaravone Market Forecast by Application (2025-2030)
  11.2.1 Global Edaravone Sales (Kilotons) Forecast by Application
  11.2.2 Global Edaravone Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Edaravone Market Size Comparison by Region (M USD)
Table 5. Global Edaravone Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Edaravone Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Edaravone Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Edaravone Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2022)
Table 10. Global Market Edaravone Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Edaravone Sales Sites and Area Served
Table 12. Manufacturers Edaravone Product Type
Table 13. Global Edaravone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Edaravone
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Edaravone Market Challenges
Table 22. Global Edaravone Sales by Type (Kilotons)
Table 23. Global Edaravone Market Size by Type (M USD)
Table 24. Global Edaravone Sales (Kilotons) by Type (2019-2024)
Table 25. Global Edaravone Sales Market Share by Type (2019-2024)
Table 26. Global Edaravone Market Size (M USD) by Type (2019-2024)
Table 27. Global Edaravone Market Size Share by Type (2019-2024)
Table 28. Global Edaravone Price (USD/Ton) by Type (2019-2024)
Table 29. Global Edaravone Sales (Kilotons) by Application
Table 30. Global Edaravone Market Size by Application
Table 31. Global Edaravone Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Edaravone Sales Market Share by Application (2019-2024)
Table 33. Global Edaravone Sales by Application (2019-2024) & (M USD)
Table 34. Global Edaravone Market Share by Application (2019-2024)
Table 35. Global Edaravone Sales Growth Rate by Application (2019-2024)
Table 36. Global Edaravone Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Edaravone Sales Market Share by Region (2019-2024)
Table 38. North America Edaravone Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Edaravone Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Edaravone Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Edaravone Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Edaravone Sales by Region (2019-2024) & (Kilotons)
Table 43. Mitsubishi Tanabe Pharma Edaravone Basic Information
Table 44. Mitsubishi Tanabe Pharma Edaravone Product Overview
Table 45. Mitsubishi Tanabe Pharma Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Mitsubishi Tanabe Pharma Business Overview
Table 47. Mitsubishi Tanabe Pharma Edaravone SWOT Analysis
Table 48. Mitsubishi Tanabe Pharma Recent Developments
Table 49. Simcere Edaravone Basic Information
Table 50. Simcere Edaravone Product Overview
Table 51. Simcere Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Simcere Business Overview
Table 53. Simcere Edaravone SWOT Analysis
Table 54. Simcere Recent Developments
Table 55. Taj Pharmaceuticals Ltd. Edaravone Basic Information
Table 56. Taj Pharmaceuticals Ltd. Edaravone Product Overview
Table 57. Taj Pharmaceuticals Ltd. Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Taj Pharmaceuticals Ltd. Edaravone SWOT Analysis
Table 59. Taj Pharmaceuticals Ltd. Business Overview
Table 60. Taj Pharmaceuticals Ltd. Recent Developments
Table 61. Sun Pharmaceutical Industries Ltd. Edaravone Basic Information
Table 62. Sun Pharmaceutical Industries Ltd. Edaravone Product Overview
Table 63. Sun Pharmaceutical Industries Ltd. Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sun Pharmaceutical Industries Ltd. Business Overview
Table 65. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 66. Unichem Laboratories Ltd Edaravone Basic Information
Table 67. Unichem Laboratories Ltd Edaravone Product Overview
Table 68. Unichem Laboratories Ltd Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Unichem Laboratories Ltd Business Overview
Table 70. Unichem Laboratories Ltd Recent Developments
Table 71. UCB India Ltd Edaravone Basic Information
Table 72. UCB India Ltd Edaravone Product Overview
Table 73. UCB India Ltd Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. UCB India Ltd Business Overview
Table 75. UCB India Ltd Recent Developments
Table 76. Piramal Healthcare Edaravone Basic Information
Table 77. Piramal Healthcare Edaravone Product Overview
Table 78. Piramal Healthcare Edaravone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Piramal Healthcare Business Overview
Table 80. Piramal Healthcare Recent Developments
Table 81. Global Edaravone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Edaravone Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Edaravone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Edaravone Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Edaravone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Edaravone Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Edaravone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Edaravone Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Edaravone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Edaravone Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Edaravone Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Edaravone Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Edaravone Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Edaravone Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Edaravone Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Edaravone Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Edaravone Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Edaravone
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Edaravone Market Size (M USD), 2019-2030
Figure 5. Global Edaravone Market Size (M USD) (2019-2030)
Figure 6. Global Edaravone Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Edaravone Market Size by Country (M USD)
Figure 11. Edaravone Sales Share by Manufacturers in 2023
Figure 12. Global Edaravone Revenue Share by Manufacturers in 2023
Figure 13. Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Edaravone Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Edaravone Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Edaravone Market Share by Type
Figure 18. Sales Market Share of Edaravone by Type (2019-2024)
Figure 19. Sales Market Share of Edaravone by Type in 2023
Figure 20. Market Size Share of Edaravone by Type (2019-2024)
Figure 21. Market Size Market Share of Edaravone by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Edaravone Market Share by Application
Figure 24. Global Edaravone Sales Market Share by Application (2019-2024)
Figure 25. Global Edaravone Sales Market Share by Application in 2023
Figure 26. Global Edaravone Market Share by Application (2019-2024)
Figure 27. Global Edaravone Market Share by Application in 2023
Figure 28. Global Edaravone Sales Growth Rate by Application (2019-2024)
Figure 29. Global Edaravone Sales Market Share by Region (2019-2024)
Figure 30. North America Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Edaravone Sales Market Share by Country in 2023
Figure 32. U.S. Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Edaravone Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Edaravone Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Edaravone Sales Market Share by Country in 2023
Figure 37. Germany Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Edaravone Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Edaravone Sales Market Share by Region in 2023
Figure 44. China Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Edaravone Sales and Growth Rate (Kilotons)
Figure 50. South America Edaravone Sales Market Share by Country in 2023
Figure 51. Brazil Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Edaravone Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Edaravone Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Edaravone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Edaravone Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Edaravone Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Edaravone Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Edaravone Market Share Forecast by Type (2025-2030)
Figure 65. Global Edaravone Sales Forecast by Application (2025-2030)
Figure 66. Global Edaravone Market Share Forecast by Application (2025-2030)


More Publications